Shreeyashi Ojha

Reporter, BioProcess Insider

Journalist covering the manufacturing and processing sectors for biopharmaceuticals globally.  

Originally from India, I am a Londoner at heart. I have recently graduated from Goldsmiths, University of London.  

Feel free to reach out to me at: [email protected].

Latest from Shreeyashi Ojha

thumbnail
Therapeutic Class
Yes, on approvals, no on profits: Why biopharma is rethinking CGTYes, on approvals, no on profits: Why biopharma is rethinking CGT
byShreeyashi Ojha
Feb 19, 2025
2 Min Read
thumbnail
Regulations
Robert F Kennedy Jr. confirmed as HHS secretaryRobert F Kennedy Jr. confirmed as HHS secretary
byJosh Abbott, Shreeyashi Ojha
Feb 18, 2025
2 Min Read

All from Shreeyashi Ojha

Facilities & Capacity
Bio-Rad's M&A ambitions continue with Stilla buyout
Bio-Rad's M&A ambitions continue with Stilla buyout
Feb 18, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Ins & Outs: New year, new bosses at Sanofi, Gilead, and Roche
Ins & Outs: New year, new bosses at Sanofi, Gilead, and Roche
Feb 13, 2025
|
3 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
CDMO Axplora bets €50M on ADC and GLP-1 growth
CDMO Axplora bets €50M on ADC and GLP-1 growth
Feb 13, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Recipharm bolsters fill/finish capacity at German site
Recipharm bolsters fill/finish capacity at German site
Feb 13, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Novo to grow Catalent? Rumor mill spins amid Trump tariff threat
Novo to grow Catalent? Rumor mill spins amid Trump tariff threat
Feb 10, 2025
|
3 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Lantheus goes Evergreen in a $250m upfront deal
Lantheus goes Evergreen in a $250m upfront deal
Feb 4, 2025
|
1 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Cell mates: SCTbio, CCRM Nordic amp up cell therapy production
Cell mates: SCTbio, CCRM Nordic amp up cell therapy production
Feb 4, 2025
|
1 Min Read
byShreeyashi Ojha, Reporter
A hand serves up an earnings graph as if it was a dish ordered at a restaurant
Facilities & Capacity
Sartorius eyes long-term growth amid market fluctuations
Sartorius eyes long-term growth amid market fluctuations
Jan 30, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
MilliporeSigma, Opentrons to automate assay kits
MilliporeSigma, Opentrons to automate assay kits
Jan 29, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Therapeutic Class
Report predicts 11.6% growth for single-use tech
Report predicts 11.6% growth for single-use tech
Jan 27, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Antibody-Drug Conjugate eBook
Sponsored Content
eBook: Antibody-Drug Conjugates — A Technology Update
eBook: Antibody-Drug Conjugates — A Technology Update
Jan 24, 2025
+4
byShreeyashi Ojha, Josh Abbottand 4 more
Facilities & Capacity
Sartorius, McMaster open Canadian bioprocessing hub
Sartorius, McMaster open Canadian bioprocessing hub
Jan 23, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Therapeutic Class
A Gen Z guide to bioprocessing trends of '25
A Gen Z guide to bioprocessing trends of '25
Jan 22, 2025
|
3 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Iconovo taps Lonza for spray-dried obesity biologic
Iconovo taps Lonza for spray-dried obesity biologic
Jan 20, 2025
|
1 Min Read
byShreeyashi Ojha, Reporter
Therapeutic Class
Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook
Thermo cites Catalent, capacity, and Trumpian tariffs in positive CDMO outlook
Jan 20, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Samsung Bio lands $1.4bn contract with undisclosed EU client
Samsung Bio lands $1.4bn contract with undisclosed EU client
Jan 16, 2025
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Lilly expands India footprint with Hyderabad plant
Lilly expands India footprint with Hyderabad plant
Jan 15, 2025
|
3 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Boehringer bolsters ADC biz with $1.3bn Synaffix deal
Boehringer bolsters ADC biz with $1.3bn Synaffix deal
Jan 13, 2025
|
1 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Insider’s wrapped: BIOSECURE, AI, CDMO shakeups shaped 2024
Insider’s wrapped: BIOSECURE, AI, CDMO shakeups shaped 2024
Dec 30, 2024
|
5 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
SK pharmteco secures $1.4bn GLP-1 deal
SK pharmteco secures $1.4bn GLP-1 deal
Dec 19, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Regulations
Novo Catalent deal clears regulatory hurdles
Novo Catalent deal clears regulatory hurdles
Dec 16, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Asahi strengthens autoimmune focus with Chiome partnership
Asahi strengthens autoimmune focus with Chiome partnership
Dec 16, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Ins & Outs: Resilience, AGC, Sartorius ride the CEO carousel
Ins & Outs: Resilience, AGC, Sartorius ride the CEO carousel
Dec 16, 2024
|
3 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Diabetes drug firms Sanofi, Novo expand global footprint
Diabetes drug firms Sanofi, Novo expand global footprint
Dec 12, 2024
|
3 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
BioMarin bolsters Ireland footprint with $63m expansion
BioMarin bolsters Ireland footprint with $63m expansion
Dec 12, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Therapeutic Class
Is India reliable? Addressing challenges in the pharma industry
Is India reliable? Addressing challenges in the pharma industry
Dec 9, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Novo expands EU footprint with $200m Novavax plant
Novo expands EU footprint with $200m Novavax plant
Dec 5, 2024
|
3 Min Read
byShreeyashi Ojha, Reporter
Therapeutic Class
India’s pharma future relies on regulatory strength
India’s pharma future relies on regulatory strength
Dec 5, 2024
|
3 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Sanofi opens AI-powered $595m facility in Singapore
Sanofi opens AI-powered $595m facility in Singapore
Dec 2, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Lonza doubles bioconjugation capacity at Swiss facility
Lonza doubles bioconjugation capacity at Swiss facility
Nov 16, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Facilities & Capacity
Cytiva strengthens APAC presence with Korea plant
Cytiva strengthens APAC presence with Korea plant
Nov 16, 2024
|
2 Min Read
byShreeyashi Ojha, Reporter
Therapeutic Class
Repligen credits 10% revenue surge to new modalities and M&As
Repligen credits 10% revenue surge to new modalities and M&As
Nov 15, 2024
|
3 Min Read
byShreeyashi Ojha, Reporter
Deal-Making
Novo taps Ascendis in $285m GLP-1 deal
Novo taps Ascendis in $285m GLP-1 deal
Nov 13, 2024
|
1 Min Read
byShreeyashi Ojha, Reporter

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Insider News
See all
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe